Danaher DHR
NYSE DHR
$212.54 +4.18 (+2.01%)
As of: Sep 17, 2026 · 3:59 PM EDT

Danaher (DHR) Total Non-Current Liabilities (2009 - 2026)

Danaher (DHR) posted Total Non-Current Liabilities of $33.3 billion for Q2 2026, up 32.9% on a QoQ basis from $25.0 billion in Q1 2026, and up 40.63% year-over-year from $23.6 billion in Q2 2025.

Analysis

Danaher (DHR) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

Danaher has reported Total Non-Current Liabilities for 18 years, with the latest figure at $33.3 billion in Q2 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 40.63% year-over-year to $33.3 billion in Q2 2026; TTM through Jun 2026 was $33.3 billion, a 40.63% increase from a year earlier, with the FY2025 full-year figure at $25.2 billion, up 13.12% from the prior year.
  • Total Non-Current Liabilities was $33.3 billion for Q2 2026 at Danaher, up from $25.0 billion in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $33.3 billion in Q2 2026, with the low at $22.3 billion in Q4 2024.
  • Average Total Non-Current Liabilities over 5 years is $25.8 billion, with a median of $25.1 billion recorded in 2025.
  • The sharpest annual moves came in 2024 and 2026: Total Non-Current Liabilities retreated 18.06% in 2024, then surged 40.63% in 2026.
  • Over 5 years, Total Non-Current Liabilities stood at $27.8 billion in 2022, then slipped by 10.02% to $25.0 billion in 2023, then retreated by 10.74% to $22.3 billion in 2024, then gained by 13.12% to $25.2 billion in 2025, then soared by 31.83% to $33.3 billion in 2026.
  • The last three Total Non-Current Liabilities figures came in at $33.3 billion (Q2 2026), $25.0 billion (Q1 2026), and $25.2 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 55.95 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 33.25 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 6.06 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 3.52 Bn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 4.05 Bn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 457.16 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 2.88 Bn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 821.06 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 197.96 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 3.06 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 26, 2026 33.25 Bn
Mar 27, 2026 25.02 Bn
Dec 31, 2025 25.22 Bn
Sep 26, 2025 23.16 Bn
Jun 27, 2025 23.65 Bn
Mar 28, 2025 22.62 Bn
Dec 31, 2024 22.30 Bn
Sep 27, 2024 23.66 Bn
Jun 28, 2024 23.01 Bn
Mar 29, 2024 24.20 Bn
Dec 31, 2023 24.98 Bn
Sep 29, 2023 28.88 Bn
Jun 30, 2023 26.69 Bn
Mar 31, 2023 26.99 Bn
Dec 31, 2022 27.76 Bn
Sep 30, 2022 26.54 Bn
Jul 1, 2022 27.61 Bn
Apr 1, 2022 29.32 Bn
Dec 31, 2021 30.31 Bn
Oct 1, 2021 30.85 Bn